1703 related articles for article (PubMed ID: 16391411)
41. A historical perspective of Helicobacter gastroduodenitis and its complications.
Egan BJ; O'Morain CA
Best Pract Res Clin Gastroenterol; 2007; 21(2):335-46. PubMed ID: 17382281
[TBL] [Abstract][Full Text] [Related]
42. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
Mazure PA
Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
[No Abstract] [Full Text] [Related]
43. Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
Cheon JH; Kim JH; Lee SK; Kim TI; Kim WH; Lee YC
Helicobacter; 2008 Dec; 13(6):564-71. PubMed ID: 19166423
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of gastric acid secretion: advantages and risks in short and long-term treatment.
Mazzacca G; Sabbatini F
Ital J Gastroenterol; 1990; 22 Suppl 1():11-2. PubMed ID: 1983419
[TBL] [Abstract][Full Text] [Related]
45. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Gorshkov VA
Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
[No Abstract] [Full Text] [Related]
46. [Changes in Helicobacter pylori gastritis caused by therapy with inhibitors of gastric acid secretion].
Stolte M; Meining A
Z Gastroenterol; 1999 Oct; 37(10):1029-36. PubMed ID: 10549099
[TBL] [Abstract][Full Text] [Related]
47. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
Malfertheiner P; Fass R; Quigley EM; Modlin IM; Malagelada JR; Moss SF; Holtmann G; Goh KL; Katelaris P; Stanghellini V; Talley NJ; Tytgat GN; Wright NA
Aliment Pharmacol Ther; 2006 Mar; 23(6):683-90. PubMed ID: 16556170
[TBL] [Abstract][Full Text] [Related]
48. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
49. The origin of 20th century discoveries transforming clinical gastroenterology.
Kirsner JB
Am J Gastroenterol; 1998 Jun; 93(6):862-71. PubMed ID: 9647010
[No Abstract] [Full Text] [Related]
50. [Gastric erosion, erosive gastritis: their forms and approaches to treatment].
Ryss ES; Fishzon-Ryss IuI
Klin Med (Mosk); 1995; 73(4):31-4. PubMed ID: 7474813
[No Abstract] [Full Text] [Related]
51. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
52. The brain on itself: Nobel laureates and the history of fundamental nervous system function.
Langmoen IA; Apuzzo ML
Neurosurgery; 2007 Nov; 61(5):891-907; discussion 907-8. PubMed ID: 18091266
[TBL] [Abstract][Full Text] [Related]
53. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
54. [Helicobacter pylori--friend or foe?].
Ciortescu I; Stan M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):619-24. PubMed ID: 21243784
[TBL] [Abstract][Full Text] [Related]
55. Gastric cancer and Helicobacter pylori infection.
Konturek PC; Konturek SJ; Brzozowski T
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():51-65. PubMed ID: 17033105
[TBL] [Abstract][Full Text] [Related]
56. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
[TBL] [Abstract][Full Text] [Related]
57. [Medical treatment of stomach ulcer except in emergency].
Bretagne JF
Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S73-S80. PubMed ID: 8734374
[No Abstract] [Full Text] [Related]
58. Gastric secretion.
Schubert ML
Curr Opin Gastroenterol; 2014 Nov; 30(6):578-82. PubMed ID: 25211241
[TBL] [Abstract][Full Text] [Related]
59. Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomach.
Ochi Y; Horie S; Maruyama T; Watanabe K; Yano S
Life Sci; 2005 Sep; 77(16):2040-50. PubMed ID: 15919097
[TBL] [Abstract][Full Text] [Related]
60. Historical perspective of gastric acid inhibition.
Díaz-Rubio M
Drugs; 2005; 65 Suppl 1():1-6. PubMed ID: 16335852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
